Australian Businesses Worried U.S. Will Ask For Biologics Changes In TPP Certification

A key Australian business group is raising concerns that the United States will demand that Australia extend their exclusivity period for biologic drugs before the Trans-Pacific Partnership agreement can enter into force for the country. “We welcome the Australian Government’s resistance to calls for increased IP terms, particularly on Biologics as negotiated in the agreement, however we are concerned that the US will attempt to renegotiate these provisions within the certification efforts post-ratification,” the Australian Chamber of Commerce and Industry...